Case Report
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Mar 15, 2025; 17(3): 100152
Published online Mar 15, 2025. doi: 10.4251/wjgo.v17.i3.100152
Figure 5
Figure 5 Timeline of the patient's treatment course. SD: Stable disease; FOLFOXIRI: 5-FU, 2800 mg/m2, 48-hour continuous intravenous (i.v.) infusion; leucovorin, 200 mg/m2i.v.; irinotecan, 165 mg/m2; oxaliplatin, 85 mg/m2i.v.